Bharat Biotech to start Phase-1 trials of Covid-19 intranasal vaccine in Feb-March

Bharat Biotech to start Phase-1 trials of Covid-19 intranasal vaccine in Feb-March Besides Covaxin, BharatBiotech has been actively working on developing another vaccine, for which it tied up with Washington UniversitySchool of Medicine in St Louis for the novel "chimp-adenovirus" (Chimpanzee adenovirus), a single dose intranasal vaccine for Covid-19. https://ift.tt/eA8V8J